Oxolife raises €5.0M Series A round

The capital will be used to develop the company's R&D program and conduct a Phase II clinical trial in European centers to evaluate the efficacy of OXO-001 in embryo implantation

Source: https://webcapitalriesgo.com/oxolife-raises-e5m-in-a-round-lead-by-inveready-and-cdti-and-also-backed-by-bstartup-highstick-2019-and-capital-cell-investors/